Erlotero 150mg

Erlotinib is a tyrosine kinase inhibitor (TKI) which is a type of cancer growth blocker.

It blocks proteins on cancer cells that encourage the cancer to grow.

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body. It is taken by mouth.